Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: The preclinical stage of Alzheimer's disease?

Acta Neuropathologica

Volumn 93, Issue 2, 1997, Pages 146-153

  Beach, T G ^a   Honer, W G ^a   Hughes, L H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acetylcholine; Aging; Alzheimer's disease; Amyloid; Amyloid protein

Indexed keywords

ACETYLCHOLINESTERASE; SYNAPTOPHYSIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC NERVE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY; DOWN SYNDROME; ENTORHINAL CORTEX; ENZYME HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; NERVE FIBER DEGENERATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE; TEMPORAL LOBE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; CHOLINERGIC FIBERS; HUMANS; MIDDLE AGED; NEUROFIBRILLARY TANGLES;

EID: 0031020840     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050595     Document Type: Article

References (67)

1. Beach TG (1987) The history of Alzheimer's disease: three debates. J Hist Med Allied Sci 42: 327-349
2. Beach TG, Honer WG (1995) Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly. Soe Neurosci Abstr 21: 1500
3. Beach TG, McGeer EG (1992) Senile plaques, amyloid β-protein, and acetylcholinesterase fibres in Alzheimer's disease striate cortex. Acta Neuropathol 83: 292-299
4. Beach TG, McGeer EG (1992) Cholinergic fiber loss in the absence of synaptophysin depletion in Alzheimer's disease visual cortex. Neurosci Lett 142: 253-256
5. Beach TG, Tago H, Nagai T, Kimura H, McGeer PL, McGeer EG (1987) Perfusion-fixation of the human brain for immunohistochemistry: comparison with immersion-fixation. J Neurosci Methods 19: 183-192
6. Bear MF, Carnes KM, Ebner FF (1985) An investigation of Cholinergic circuitry in cat striate cortex using acetylcholinesterase histochemistry. J Comp Neurol 234: 411-430
7. Beyreuther K, Pollwein P, Multhaup P, Monning U, Konig G, Dyrks T, Schubert W, Masters CL (1993) Regulation and expression of the Alzheimer's β/A4 amyloid protein precursor in health, disease and Down's syndrome. Ann NY Acad Sci 695: 91-102
8. Bouras C, Hof PR, Panteleimon G, Michel JP, Morrison JH (1994) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex 4: 138-150
9. Bowen DM, Davison AN (1986) Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease. Br Med Bull 42: 75-80
10. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
11. Burger PC, Vogel FS (1973) The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am J Pathol 73: 457-76
12. Campbell SK, Switzer RC, Martin TL (1987) Alzheimer's plaques and tangles: a controlled and enhanced silver-staining method. Soc Neurosci Abstr 13: 678
13. Crystal H, Dickson D, Fuld P, et al (1988) Clinicopathologic studies in dementia: non-demented subjects with pathologically confirmed Alzheimer's disease. Neurology 38: 1682-1687
14. Crystal HA, Dickson DW, Sliwinski MJ, Lipton RB, Grober E, Marks-Nelson H, Antis P (1993) Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 34: 566-573
15. Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL (1988) A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 38: 1688-1693
16. Delaere P, Duyckaerts C, Masters C, Beyreuther K, Piette F, Hauw JJ (1990) Large amounts of neocortical BA4 deposits without neuritic plaques or tangles in a psychometrically assessed, non-demented person. Neurosci Lett 116: 87-93
17. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ (1991) Subtypes and differential laminar distributions of β-A4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 81: 328-325
18. Dickson DW, Crystal HA, Mattiacc LA, Masur DM, Blau AD, Davies P, Yeji SH, Aronson MK (1991) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13: 179-189
19. Reference deleted
20. Duyckaerts C, Delaere P, Poulain V, Brion JP, Hauw JJ (1988) Does amyloid precede paired helical filaments in the senile plaque? A study of 15 cases with graded intellectual status in aging and Alzheimer disease. Neurosci Lett 91: 354-359
21. Ebly EM, Parhad IM, Hogan DB, Fung TS (1994) Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology 44: 1593-1600
22. Flicker C, Dean RL, Watkins DL, et al (1983) Behavioural and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacol Biochem Behav 18: 973-981
23. Francis PT, Webster MT, Chessell IP, et al (1993) Neurotransmitiers and second messengers in aging and Alzheimer's disease. Ann NY Acad Sci 695: 19-26
24. Fuld PA, Dickson D, Crystal H, Aronson MK (1987) Primitive plaques and memory dysfunction in normal and impaired elderly persons. N Engl J Med 316: 756
25. Galdzicki Z, Fukuyuma R, Wadhwani K, et al (1994) β-amyloid increases choline conductance of PC 12 cells: possible mechanism of toxicity in Alzheimer's disease. Brain Res 646: 332-336
26. Geula C, Mesulam MM (1989) Cortical cholinergic fibers in aging and Alzheimer's disease: a morphomeiric study. Neuroscience 33: 469-481
27. Honer WG, Dickson DW, Gleeson J, Davies P (1992) Regional synaptic pathology in Alzheimer's disease. Neurobiol Aging 13: 375-382
28. Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner L, Hu G, Boulianne L, Lu Z, Trimble WS (in press) Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience
29. Ishii T, Kametani F, Haga S, Satoh M (1989) Subsequences of amyloid precursor protein in Alzheimer brain. In: Iqbal K, Wisniewski H, Winblad B, (eds) Alzheimer's disease and related disorders: progress in clinical and biological research. Liss, New York, pp 965-970
30. Ishii T, Kametani F, Haga S, Sato M (1989) The immunohistochemical demonstration of subsequences of the precursor of the amyloid A4 protein in senile plaques in Alzheimer's disease. Neuropathol Appl Neurobiol 15: 135-147
31. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A (1988) Clinical, pathological and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23: 138-144
32. Kelley PH, Malanowski J, Wiederhold KH, Gremlich HU (1993) Investigation of the toxicity of β-amyloid for basal forebrain cholinergic neurons. Soc Neurosci Abstr 19: 833
33. Lowe SL, Francis PT, Procter AW, Palmer AM, Davison AN, Bowen DM (1988) Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer disease. Brain 111: 785-799
34. Mann DMA (1993) Association between Alzheimer disease and Down syndrome: neuropathological observations. In: Berg JM, Karlinsky H, Holland AJ (eds) Alzheimer disease, Down syndrome and their relationship. Oxford University Press, Oxford, pp 71-92
35. Mann DMA, Esiri MM (1989) The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 89: 169-179
36. Masliah E, Terry RD, Alford M, DeTeresa R (1990) Quantitative immunohistochemistry of synaptopysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections, J Histochem Cytochem 38: 837-844
37. Masliah E, Terry RD, Mallory M, Alford M, Hansen LA (1990) Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol 137: 1293-1297
38. Masters CL, Beyreuther K (1994) Alzheimer's disease: a clearer definition of the genetic components. Med J Aust 160: 243-244
39. Masur D, Crystal H, Dickson D, et al (1992) Association of neuropathology with patterns of neuropsychological decline in elderly subjects. Neurology 42 [Suppl 3]: 359
40. McGeer PL, McGeer EG, Suzuki J, Dolman CE, Nagai T (1984) Aging, Alzheimer's disease and the cholinergic system of the basal forebrain. Neurology 34: 741-745
41. McGeer PL, Akiyama H, Kawamata T, Yamada T, Walker DG, Ishii T (1992) Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy. J Neurosci Res 31: 428-442
42. Mesulam MM, Geula C (1992) Overlap between acetylcholinesterase-rich and choline acetyltransterase-positive (cholinergic) axons in human cerebral cortex. Brain Res 577: 112-120
43. Mirra SS, Heyman A, McKeel D, et al (1991) The Consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
44. Mirra SS, Hart MN, Terry RD (1994) Making the diagnosis of Alzheimer's disease - a primer for practicing pathologists. Arch Pathol Lab Med 117: 132-144
45. Morris JC, McKeel DW, Storandt M, et al (1991) Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging, Neurology 41: 469-478
46. Mufson EJ, Kehr AD, Wainer BH, Mesulam MM (1987) Cortical effects of neurotoxic damage to the nucleus basalis in rats: persistent loss of extrinsic cholinergic input and lack of transsynaptic effect upon the number of somatostatin-containing, cholinesterase-positive and cholinergic cortical neurons. Brain Res 417: 385-388
47. Nordberg A, Nilsson-Hakansson L, Adem A, Hardy J, Alafuzoff I, Lai Z, Herrera-Marschitz M, Winblad B (1989) The role of nicotinic receptors in the pathophysiology of Alzheimer's disease. Prog Brain Res 79: 353-362
48. Ott A, Breteler MMB, Harskamp F van, et al (1995) Prevalence of Alzheimer's disease and vascular dementia: association with education. BMJ 310: 970-973
49. Pearson RCA, Powell TPS (1987) Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease. J Neural Transm [Suppl] 24: 139-146
50. Perry EK, Perry RH (1985) A review of neuropathological and neurochemical correlates of Alzheimer's disease. Dan Med Bull 32 [Suppl 1]: 27-34
51. Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH (1992) Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging 13: 393-400
52. Perry EK, Court JA, Lloyd S, Johnson M, Griffiths MH, Spurden D, Piggott MA, Turner J, Perry RH (1996) β-amyloidosis in normal aging and transmitter signaling in human temporal lobe. Ann NY Acad Sci 777: 388-392
53. Price JL, Davis PB, Morris JC, White DL (1991) The distribution of tangles, plaques and related imrnunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 12: 295-312
54. Procter AW, Lowe SL, Palmer AM, Francis PT, Esiri MM, Stratmann GC, Naijlerahim A, Patel AJ, Hunt A, Bowen DM (1988) Topographical distribution of neurochemical changes in Alzheimer's disease. J Neurol Sci 84: 125-140
55. Rieke GK (1995) Are cholinergic neurons of the basal forebrain destroyed in vivo by chronic challenge with amyloid fragments β1-42 or β1-40? Soc Neurosci Abstr 21: 474
56. Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL (1989) Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320: 1446-1452
57. Sparks DL, Liu H, Scheff SW, Coyne CM, Hunsaker JC (1993) Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J Neuropathol Exp Neurol 52: 135-142
58. Tagliavini F, Giaccone G, Frangione B, Bugiani O (1988) preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett 93: 191-196
59. Tago H, Kimura H, Maeda T (1986) Visualization of detailed acetylcholinesterase fiber and neuronal staining in rat brain by a sensitive histochemical procedure. J Histochem Cytochem 34: 1431-1438
60. Tago H, McGeer PL, McGeer EG (1987) Acetylcholinesterase fibers and the development of senile plaques. Brain Res 406: 363-369
61. Wolozin B, Pruchnicki A, Dickson DW, Davies P (1986) A neuronal antigen in the brains of Alzheimer patients. Science 232: 648-650
62. Yamaguchi H, Hirai S, Morimatsu M, et al (1988) Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol 77: 113-119
63. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y (1989) Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta-protein immunostain. Acta Neuropathol 77: 314-319
64. Yamaguchi H, Nakazato Y, Hirai S, Shoji M, Harigaya Y (1989) Electron micrograph of diffuse plaques: initial stage of senile plaque formation. Am J Pathol 135: 593-597
65. Yamaguchi H, Nakazato Y, Hirai S, Shoji M (1990) Immunoelectron microscopic localization of amyloid beta-protein in the diffuse plaques of Alzheimer-type dementia. Brain Res 508: 320-324
66. Yamaguchi H, Nakazto Y, Shoji M, Takatama M, Hirai S (1991) Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type; comparison with primitive plaques. Acta Neuropathol 82: 13-20
67. Yamakazi T, Yamaguchi H, Nakazato Y, Ishiguro K, Kawarabayashi T, Hirai S (1992) Ultrastructural characterization of cerebellar diffuse plaques in Alzheimer's disease. J Neuropathol Exp Neurol 51: 281-286